ACUTAAS vs SHUKRAPHAR: Stock Comparison
ACUTAAS CHEMICALS shows a higher dividend yield, faster revenue growth and a higher net margin, while SHUKRA PHARMACEUTICALS L shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ACUTAAS leads 6; SHUKRAPHAR leads 3 of 9
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ACUTAAS | SHUKRAPHAR |
|---|---|---|
| Sector | Healthcare | — |
| Industry | Pharmaceuticals | — |
Price
| Metric | ACUTAAS | SHUKRAPHAR |
|---|---|---|
| Live Price | ₹3,308.5 | ₹54.36 |
| Day Change | -1.08% | -0.44% |
| Volume | 1.09 L | 10.95 L |
| 52-Week High | ₹3,740 | ₹58.2 |
| 52-Week Low | ₹1,302 | ₹40.06 |
| Distance from 52W High | -11.54% | -6.6% |
Valuation
| Metric | ACUTAAS | SHUKRAPHAR |
|---|---|---|
| Market Cap | ₹26,993 Cr | ₹0 Cr |
| P/E Ratio | 71.34x | 63.03x |
| P/B Ratio | 16.66x | 21.83x |
| EPS | ₹47.03 | ₹0.34 |
| Book Value | ₹201.93 | ₹2.05 |
| Dividend Yield | 0.08% | 0.02% |
Growth
| Metric | ACUTAAS | SHUKRAPHAR |
|---|---|---|
| Revenue Growth (TTM YoY) | 40.3% | 0% |
| EPS Growth (TTM YoY) | 105.6% | 0% |
| Qtr Sales Growth | -2.2% | 0% |
| Qtr Profit Growth | 1.2% | 15.98% |
Profitability & Leverage
| Metric | ACUTAAS | SHUKRAPHAR |
|---|---|---|
| ROE | 20.83% | — |
| ROCE | 23.33% | — |
| Net Margin | 26.6% | 0% |
| Operating Margin | 36.29% | — |
| Debt to Equity | 0.02x | — |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ACUTAAS | SHUKRAPHAR |
|---|---|---|
| Promoter Holding | 32.66% | 50.96% |
| FII Holding | 21.61%▲ 2.13 pp | 0% |
| DII Holding | 19.56%▼ 0.04 pp | 0.11% |
| Public Holding | 26.16%▼ 2.08 pp | 48.92%▼ 0.01 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ACUTAAS CHEMICALS and SHUKRA PHARMACEUTICALS L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.